-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

--Morgan Stanley Adjusts TransMedics Group's Price Target to $63 From $54, Keeps Equalweight Rating

--Morgan Stanley Adjusts TransMedics Group's Price Target to $63 From $54, Keeps Equalweight Rating

MT Newswires · 01/06/2023 06:56